Sterling
Eli Lilly logo
Eli Lilly
Viking Therapeutics logo
Viking Therapeutics

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Eli Lilly 22.974, Viking Therapeutics 0.

Eli Lilly vs Viking Therapeutics Net Worth and Market Cap

Eli Lilly (LLY) and Viking Therapeutics (VKTX) are peers in GLP-1. Eli Lilly reported revenue of $23.0B as of Q2 2026, compared with $0 for Viking Therapeutics. Eli Lilly leads on revenue.

Key differences

  • Eli Lilly's KPIs on Sterling include Cardiometabolic Manufacturing Capex Announcements by Site (Cumulative) and Foundayo Quarterly Revenue.
  • Viking Therapeutics's KPIs on Sterling include Cash + Short-Term Investments (Quarterly) and Viking Oral VK2735 Phase 3 Timing.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Viking Therapeutics.
MetricEli LillyViking Therapeutics
Market Cap--
Revenue$22.97B$0
Cost of Revenue$3.27B$0
Gross Profit$19.71B$0
Operating Income$12.46B$-164.00M
Net Income$7.09B$-158.00M
R&D Expense$3.82B$150.00M
Earnings Per Share$7.94-$1.37
Gross Margin85.8%-
Operating Margin54.2%-
Net Profit Margin30.9%-
Free Cash Flow$7.76B$-114.00M
Cumulative Free Cash Flow$109.66B$-747.00M
Operating Cash Flow$10.69B$-114.00M
Cash & Equivalents$8.89B$118.00M

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites